Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


StemCells, Inc. Reports Positive Interim Data From Spinal Cord Injury Trial 

 

 

StemCells, Inc. Reports Positive Interim Data From Spinal Cord Injury Trial

September 3, 2012 - (StemCells, Inc.) - "StemCells, Inc. today announced that interim six-month data from the first patient cohort in the Company's Phase I/II clinical trial of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) for chronic spinal cord injury continues to demonstrate a favorable safety profile, and shows considerable gains in sensory function in two of the three patients compared to pre-transplant baselines."  Read Full Article

 

Posted on 6-Sep-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: